Journal Article

Effectiveness of Methoprene, an Insect Growth Regulator, Against Temephos-Resistant <i>Aedes aegypti</i> Populations from Different Brazilian Localities, Under Laboratory Conditions

in Journal of Medical Entomology

Published on behalf of Entomological Society of America

Volume 42, issue 5, pages 830-837
Published in print September 2005 | ISSN: 0022-2585
Published online October 2014 | e-ISSN: 1938-2928 | DOI:

More Like This

Show all results sharing these subjects:

  • Disease Ecology and Epidemiology
  • Entomology


Show Summary Details


The susceptibility of Aedes aegypti (L.) larvae from several Brazilian populations to the juvenile hormone analog methoprene and the organophosphate insecticide temephos were investigated. Populations from Natal (northeastern region), Macapá (northern region), and Jardim América, Rio de Janeiro (southeastern region) are temephos-resistant (RR90 = 24.4, 13.3, and 15.8, respectively), whereas populations from Presidente Prudente (southeastern region) and Porto Velho (northern region) exhibit only an incipient temephos-altered susceptibility status (RR90 = 1.8 and 2.6, respectively). Biochemical assays revealed alterations of the enzymes implicated in metabolic resistance, glutathione S-transferase, mixed function oxidases and esterases, among these populations. Dose–response assays showed at most a low resistance to methoprene of all populations tested, irrespective of their temephos resistance level. However, sequential exposure of Macapá and Natal populations to temephos and methoprene indicated a potential cross-resistance when larvae are exposed to both insecticides. Nevertheless, susceptibility of the Brazilian Ae. aegypti populations to methoprene alone suggests this insect growth regulator could substitute for temephos in the control of the dengue vector in the country.

Keywords: methoprene; Aedes aegypti; temephos; vector control; insect growth regulator

Journal Article.  4529 words.  Illustrated.

Subjects: Disease Ecology and Epidemiology ; Entomology

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.